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Summary The fluorescent stain Hoechst 33342, when injected i.v. into mice, has an LD50 of 300 gg-1. The
stain exits rapidly from the blood, with a half-life of 110 sec following an injection of I0sg g-1, but remains
bound within target cells, redistributing with a half-life longer than 2h. This results in a gradient of drug
binding outward from capillaries which can be used to estimate regional perfusion via fluorescence
microscopy of frozen tissue sections. For tumour tissues that can be dispersed into single cell suspensions,
intracellular Hoeschst 33342 can be quantified by flow cytometry, and cell populations can be selected on the
basis of their fluorescence (distance from the vasculature) using a fluorescence-activated cell sorter. Our
results in tumours and in spheroids indicate that the rate of stain uptake by different cell subpopulations in
situ is much more dependent on stain delivery than on selective uptake. Retention of the stain in spheroids is
sufficiently stable to allow cell sorting several hours post-injection. Hoechst 33342 thus appears to have
considerable potential as an agent for quantifying tissue perfusion, and for allowing selection of tumour cell
subpopulations to assess response to radiation and drugs.
The bisbenzamide Hoechst 33342 (H-33342), a
DNA-binding fluorescent stain, first received
attention due to its potential for quantifying the
DNA content of living cells (Arndt-Jovin & Jovin,
1977). Unfortunately, cellular tolerance of the agent
is highly variable, and only a few cell lines can
withstand the stain concentrations needed for high-
resolution studies (Pallavicini et al., 1979; Szabo et
al., 1981; Durand & Olive, 1982). Other useful
properties of the stain have emerged, however, at
lower (non-toxic) concentrations: uptake is highly
dependent upon cell type, rather than DNA content
(Loken, 1980; Lalande et al., 1981) and in tumours,
penetration by H-33342 is a very slow process
(Chaplin et al., 1985).
We have utilized the slow penetration rate of this
fluorescent agent, in conjunction with fluorescence-
activated cell sorting, as a means of selectively
recovering cells at different depths within spheroids
in vitro (Durand, 1982), or as a function of distance
from the vasculature in experimental tumours
(Chaplin et al., 1985). In either system, under our
normal experimental protocols, we have been
unable to demonstrate any toxicity at these low
concentrations of H-33342, and we seldom see any
indication of an interaction with other anti-tumour
agents, unlike other studies at higher stain
concentrations (Priesler, 1978; Pallavicini et al.,
1979; Smith & Anderson, 1984). As might be
expected, staining patterns can be reproduced more
easily in the spheroid system than in tumours; we
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have evidence that both variability of tumour blood
flow, and of injection technique, lead to inter-
tumour variation in staining intensity (Chaplin et
al., submitted for publication).
Although our procedures are adequate to allow
study of anti-tumour agents on selected cell sub-
populations in both systems, a concern is that
'technical' problems may limit the use of this
method for sorting tumour cells. For example, our
techniques explicitly assume that H-33342, once
delivered, remains bound within the same cell at
least until the conclusion of the sorting procedure.
In fact, redistribution has been found to occur in
tumours (Reinhold & Visser, 1983) and in single
cells (Olive, 1985), although the rate of redistri-
bution has not been investigated. Further, we have
assumed that in vivo where it is impossible to 'wash
out' excess stain, no free stain is available to
the cells during the disaggregation procedures. Both
questions are addressed in detail in this com-
munication. As spheroids can be conveniently
studied in a sequential manner, we have also
assessed the 'stability' of the staining gradient after
removal of the H-33342.
A further problem is suggested by the observed
gradient of binding/staining intensities itself. H-
33342 binds exclusively to DNA, and thus at high
stain concentrations a cell is limited in its binding
potential by its DNA content. At much lower stain
concentrations, however, the limitation seems likely
to be related to stain delivery, rather than DNA
content. In both systems, cell size heterogeneity
presents problems, since a bigger cell might be
expected to see and 'collect' more stain. We have
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addressed the relevance of this question by inter-
comparing sorting based on intracellular H-33342
intensity, or based on the ratio of the Hoechst
intensity signal to peripheral light scatter signal
(essentially, the ratio of 'intensity' to 'volume', or,
an estimate of H-33342 'concentration').
Perhaps the most critical assumption made in our
sorting procedure is that the various subpopulations
of cells in the tumour or spheroid all have the same
inherent capacity for uptake of the H-33342, i.e.,
that the heterogeneity of staining which forms the
basis of our ability to separate cells is entirely a
function of stain delivery to the cells. There is
abundant evidence that functionally different
isolated cells show differential uptake of low-
concentration Hoechst 33342 (Lalande et al., 1981;
Loken, 1980). Unfortunately, we are unable to
perform an 'absolute' control experiment to test
heterogeneity of uptake within a single tumour: we
cannot isolate cells from the different regions of a
tumour without using our staining/sorting protocol.
We have, however, measured the uptake of addi-
tional H-33342 in the separated cell populations,
to determine whether under such controlled condi-
tions, differences in cell permeability or other
factors influence H-33342 binding.
Materials and methods
Chemicals
Hoechst 33342 and adriamycin were purchased
from Sigma Chemical Co., and stock solutions of
each were prepared in sterile distilled water.
Spheroids
Chinese hamster V79 lung fibroblasts were
maintained as exponentially growing monolayers in
minimal essential medium (MEM) containing 10%
foetal bovine serum (FBS) from Gibco. Spheroids
were initiated by seeding 2 x 106 cells into Bellco
spinner culture flasks containing 200ml of MEM
plus 5% FBS. Medium was replaced daily after the
third day, and spheroids were used for experiments
- 10 days after seeding when they were 0.6 to
0.7mm diam.
For examination of H-33342 loss and transfer,
spheroids were exposed for 30min to 1-25 Mm, and
then washed repeatedly by replacing the medium
with 200ml MEM plus 5% FBS every 30min
during the post-incubation period. Spheroids were
trypsinized for 8min at 37°C in 0.25% trypsin,
placed in medium, then pipetted vigorously several
times to obtain single cells for FACS analysis. For
experiments measuring the toxicity of adriamycin,
spheroids were incubated for 20min with 2pM H-
33342 and then washed and divided into 6 groups.
Three were immediately exposed to 5gml-1
adriamycin for 30mins. The other groups were
washed again after 2.5h and then resuspended in
medium containing adriamycin. Single cells
obtained from these spheroids were sorted and
plated into 100mm diameter petri dishes containing
10ml MEM plus 10% FBS. Eight days layer,
colonies were stained with malachite green and
counted.
Mice/tumour
The SCCVII/St carcinoma originated spontaneously
in the abdominal wall of a C3H mouse in the
laboratory of Dr H. Suit, Massachussetts General
Hospital. Our specimen of the tumour was obtained
in 1983 from Dr M. Horseman of Stanford
University and has been maintained by inoculation
of tumour brei into the gastrocnemius muscle of
inbred female C3H/He mice. Tumours required for
experimentation were derived by subcutaneous in-
jection of 5 x 105 viable tumour cells (obtained by
enzymic digestion) into the sacral region of the
back. Tumours with a mean diameter of 6-8mm
were used in the present study.
H-33342 was dissolved in sterile PBS and injected
i.v. into mice (0.25ml) via the lateral tail vein.
Blood levels of H-33342 were measured at various
times following i.v. injection of 10Mgg1 mouse.
For each measurement, a 50Ml blood sample was
obtained from the orbital sinus and precipitated in
1 ml of ethanol. After centrifugation, the super-
natant was analysed for fluorescence using a
Farrand spectrofluorimeter with excitation at
343nm and emmission at 484nm. Blood levels in
mice were determined by reference to fluorescence
intensities obtained using blood samples containing
known concentrations of H-33342.
Tumour cell suspensions were prepared by
excising the tumour 20min after i.v. injection of
2ugg-1 H-33342. The tumour was washed with
PBS, and chopped using crossed scalpels. The
resulting fragments were then disaggregated by
gentle agitation for 30min at 37°C with an enzyme
cocktail of 0.02% trypsin, 0.05% DNAse and
0.05% collagenase. The resulting cell suspension
was filtered through polyester mesh (50gm pore
size), centrifuged, and the cell pellet resuspended in
medium for analysis using flow cytometry.
For analysis of tumour cell viability, the soft
agar clonogenic assay of Courtenay (1976) was
used. The plating efficiency of SCCVII tumour cells
was routinely 0.25 to 0.4 when incubated under a
5% oxygen atmosphere.
Flow cytometry and sorting
Cells from tumours and spheroids were analysedPHARMACOKINETICS OF HOECHST 33342 741
and sorted using a Becton Dickinson FACS 440
dual argon laser instrument. H-33342 intensity was
measured using excitation at 350-360nm (40mW
power) with emission monitored with a 449+10nm
band pass filter. In most experiments, the fluo-
rescence intensity of H-33342 stained cells was
divided by the peripheral light scatter signal from
the 488nm laser beam (using a 488+10nm band-
pass filter) for each cell to obtain an estimate of
cellular 'concentration' of H-33342. In order to
recover all of the tumour cells, the sort windows
included some normal cells, primarily in the
brightest 10-20% of the population. Debris could
not be easily distinguished from the dimmest 10%
of the population. The fluorescence distributions
were generally divided into 10 fractions (sort
windows) based on the H-33342 intensity or
concetration, with each fraction containing 10% of
the population. In addition to the 10 sorted
fractions, an 'all-sort' was also collected to measure
the average response of the tumour or spheroid
cells to treatment.
For experiments using adriamycin, a defined
number of cells was sorted into tubes containing
5mlMEM+10% FCS which were then poured
directly into petri dishes, with two rinses of the
same tube. In this way a very accurate measure of
the number of cells plated was obtained (Durand,
submitted for publication). Adriamycin did not
change the H-33342 staining profile in spheroids,
and no additional toxicity could be attributed to
interactions with H-33342 (Durand, 1981).
Results
H-33342 concentration in the blood of mice
following i.v. administration decreased exponen-
tially with a half-life of 110sec (Figure 1). The
initial blood concentration (- 140 Mm) was rapidly
decreased as H-33342 was bound by tissues and
eliminated by the kidney. This rapid removal from
the blood suggests that tumours excised 20min
following H-33342 injection will be exposed to
negligible free H-33342 during the disaggregation
procedure (when the small tumour blood volume is
diluted many fold with trypsin), and cells which
were distant from the blood supply would therefore
remain dimly fluorescent. However, previous
studies with V79 cells showed that about half the
H-33342 fluorescent was lost from dispersed cells
within 2-3h at 370C (Durand & Olive, 1982). The
possibility therefore existed that H-33342 from
brightly-stained cells could transfer to more dimly-
stained cells during the staining and disaggregation
procedures.
To simulate tumour cord histology in a more
100
i
0 L-
C.)
c
0
C-)
10
1.0
0.1
0
0
0
0
0 5 10
Time (min)
15
Figure 1 Blood levels of Hoechst 33342 in C3H mice
following i.v. injection of lOigg-g mouse. Values of
H-33342 less than 0.2yM could not be detected due to
the background fluoresence of the blood.
controlled situation, and where multiple sampling
was possible, the 'redistribution' of H-33342 was
studied using 0.7mm diameter Chinese hamster V79
spheroids exposed for 30min to doses of H-33342
from 1-25 M (Figure 2). Rather than dissociating
spheroids immediately after H-33342 treatment,
some were left intact in suspension culture for up
to 3h. Spheroids were given 200ml fresh medium
every 30min during the post-incubation period to
remove any drug lost from the surface (thus
simulating the rapid removal of H-33342 from the
blood of mice). At specified times, spheroids were
trypsinized, and cells were analysed for H-33342
content. As can be seen in Figure 2, about half of
the H-33342 was lost by 2h after treatment,
although the remaining stain was lost at a much
slower rate, as previously reported for single cells
(Durand & Olive, 1982). Since cells stained with
1gM H-33342 showed the same rate of loss as cells
exposed to 25pM, it seems likely that the extensive
media changes during the post-incubation period
were adequate to remove most of the H-33342
which was lost into the medium from the surface of
the spheroids.
H-33342 lost from the brightly-stained external
cells of spheroids may also diffuse further into the
spheroid, so that the gradient or differential of drug
binding should decrease with time after staining. To
measure transfer of H-33342, spheroids were
exposed for 30min to the drug and then left intact
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Figure 2 Loss of Hoechst 33342 from Chinese
hamster V79 spheroids. Spheroids were incubated with
H-33342 for 30min at the concentrations indicated.
(0) 25 uM; (A) 10yM; (A) 5yM; (0) 1p M. The
mean cellular fluorescence of cells obtained from these
spheroids at various times after treatment was
determined using flow cytometry.
for up to 3 h. The profile of cell fluorescence
through the spheroid was measured by analysing
single cells from spheroids for H-33342 content
immediately after staining and at subsequent
intervals (Figures 3,4). The external cells of the
spheroids were significantly more fluorescent than
the internal cells, even 3h following H-33342
treatment. However, with time after exposure, the
external cells lost fluorescence, and the internal cells
became more fluorescent. Thus, the gradient of H-
33342 binding through the spheroid decreased with
time, so that 10% fractions from spheroids dis-
sociated immediately after treatment with 1 M H-
33342 showed a 300-fold range in values for mean
cellular fluorescence, but after 3h, this range was
reduced to - 100 (Figure 3a) (i.e., the brightest
10% of the cells were 100 times more fluorescent
than the dimmest 10%). Similar results were
obtained for 25,M H-33342 with a decrease in
heterogeneity of binding from -200 to 35.
Figure 4 shows additional data for cells from
individual sort windows, again indicating that
internal cells of spheroids became more fluorescent
with time after H-33342 treatment, even though the
average cellular response was loss of fluorescence
(dotted line in Figure 4). In fact, for spheroids
exposed to 1gM H-33342, 70% of the cells of the
spheroid showed an increase in fluorescence
intensity although the mean cellular fluorescence of
all cells decreased by 50% after 3h. However, while
H-33342 redistribution occurred, it is apparent that
a large gradient of binding through the spheroid
remained even 3h following treatment.
To evaluate whether this gradient remained
adequate to distinguish internal from external cells
of spheroids, spheroids first exposed to H-33342 for
20min were then treated immediately with
5pgml1 adriamycin, or were left for 2.5h before
incubation with adriamycin. Adriamycin was
chosen for two reasons. First, previous studies
using H-33342 to sort cells from spheroids showed
that adriamycin penetrated poorly into spheroids so
that a steep gradient of cell killing was observed
(Durand, 1981). Such a gradient is convenient for
determining whether the H-33342 gradient was
adequate for cell separation (i.e., if all cells of a
spheroid responded identically to adriamycin, then
the resolving power of H-33342 could not be
tested). The second reason for using adriamycin is
that work by Preisler (1978) suggested an inter-
action between H-33342 and adriamycin which we
wanted to investigate at the lower stain concentra-
tions used in our system. Three separate popula-
tions of spheroids were indepedently exposed to
adriamycin at both times, in order to evaluate the
reproducibility of the technique. Spheroids were
then sorted on the basis of H-33342 concentration
into 10 sort windows which were analysed for
adriamycin-induced cell killing. As shown in Figure
5, reproducibility was excellent and the average
response of spheroids exposed to adriamycin
immediately or 2.5h after H-33342 treatment was
not significantly different. Therefore, average cell
survival was independent of when the spheroids
saw H-33342, showing that H-33342 is non-toxic
and suggesting that it does not interact with
adriamycin. Previous results comparing the toxicity
of adriamycin with or without H-33342 in spheroids
support this conclusion (Durand, 1982). While both
panels showed greater killing of external cells by
adriamycin, there was greater resolution (as defined
by greater differential survival) in spheroids treated
immediately after H-33342 exposure (the decrease
in survival in window 10 is the result of inclusion of
cell debris). More toxicity was observed in the
brightly stained spheroid cells sorted immediately
after H-33342 treatment than 2.5h later, suggesting
some redistribution of H-33342 in these cells with
time after H-33342 treatment. However, since
tumour cells are routinely sorted within 1 h of
excision, redistribution of H-33342 is not likely to
interfere significantly with resolution of cell
populations on the basis of distance from the blood
supply.
_PHARMACOKINETICS OF HOECHST 33342 743
a b
0)
Ce
c 0
U
a)
a)
I.I
0 2 4 6 8 10
Sort window
Figure 3 Transfer of Hoechst 33342 between cells of spheroids. Spheroids were exposed to (a) 1 gM or (b)
25gM H-33342 for 30min and then either disaggregated immediately (Oh; 0) or 3h after treatment (A).
Single cells from these spheroids were analysed for fluorescence using flow cytometry. Each sort window
represents 10% of the population, with the most fluorescent cells being the external cells of the spheroid.
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Figure 4 Transfer of Hoechst between cells of spheroids. Spheroids were exposed to (a) 1pM or (b) 25pM
H-33342 for 30min, then disaggregated at various times after treatment. Cells were sorted, on the basis of
fluorescence, into windows representing 10% of the population (see Figure 3). These windows were then
analysed for fluorescence intensity. Selected windows are designated on the left hand side of each panel. The
dotted line represents the average response of all of the cells ('all-sort').
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Figure 5 Response of spheroids to adriamycin immediately and 2.5h after exposure to Hoechst 33342.
Spheroids were exposed to 2Mm H-33342 for 20min, washed and incubated either immediately with 5Mgml
-
adriamycin for 30min (a) or 2.5h later (b). The three different symbols represent 3 different populations
exposed independently to adriamycin. Symbols at sort window '0' represent the average response of all of the
cells of the spheroids. Cell debris is included in window 10.
With cells of spheroids, binding of H-33342
appears exclusively dependent on cell position
within the spheroid. However, in more hetero-
geneous cell systems such as tumours, other factors
such as cell permeability (Loken, 1980; Lalande
et al., 1981) might influence binding of H-33342 so
that H-33342 content or even concentration (ratio of
intensity to cell size) may not accurately indicate
the position of a cell relative to the blood supply.
If binding of H-33342 to subpopulations of
tumours is dependent on factors other than cell
size, then the rate of binding should differ in
tumour cell subpopulations sorted on the basis of
H-33342 content, and exposed in vitro to addi-
tional H-33342. Therefore, an SCCVII tumour was
exposed to H-33342 by i.v. injection of 10 pgg-1.
The tumour was excised and single cells were
analysed for H-33342 content as shown in
Figure 6a. Tumour cells were then sorted into 4
equal populations on the basis of H-33342, and re-
exposed to additional H-33342. Subsequent binding
rates varied -2-fold with cells from poorly
vascularized areas binding at about half the rate as
cells next to the vasculature, probably due to
differences in cell volume. Therefore, uptake of H-
33342 in situ, at least in the SCCVII tumour,
appears to depend primarily on cell location
relative to the blood supply.
Finally, to address the possible toxicity of H-
33342, SCCVII tumour cells were exposed in vitro
for 2h to H-33342, and then clonogenicity and
mean cell fluoresence were measured. Concen-
trations of H-33342 greater than 30pm, corres-
ponding to a mean cell fluorescence 500 times
the background, were required to produce signifi-
cant cell killing (Figure 7). Since the brightest 10%
of tumour cells exposed in situ are only - 10 times
more fluorescent than background (Figure 6a), it
is apparent that we are well below concentrations
of H-33342 necessary for toxicity to these cells.
Discussion
H-33342 appears to be a very useful agent for
viable cell selection and sorting. It is non-toxic at
the concentrations required for tumour cell sorting,
penetrates slowly into poorly vascularized tissue, and
is also lost slowly from these tissues. Redistribution
does occur but is minimal over the 30-60min
required for tumour disaggregation and does not
significantly affect the resolution of cell position
through the tumour cord.
Previous studies have indicated that not all cells
bind H-33342 to the same extent, even those cells
containing the same amount of DNA (Loken, 1980;
Lalande et al., 1981). Differences in permeability of
cells to H-33342 by different CHO cell lines
resulted in a 7-fold difference in cellular fluor-
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Figure 6 Uptake of Hoechst 33342 by SCCVII tumour cells. A C3H mouse bearing a 350mg SCCVII
tumour was injected i.v. with 2pgg-1 H-33342 20min before removing the tumour. The tumour cells were analysed for fluorescence intensity (a) as in Figure 3. Cells were divided according to fluorescence intensity into 4 sort windows each representing 25% of the population. 2 x 105 cells were sorted and reincubated with 0.5gIM H-33342 for various times, when samples were removed for analysis of mean cell fluorescence (b). (0) brightest 25%; (A) 50-75%; (A) 25-50%; (0) dimmest 25%.
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Figure 7 Toxicity of Hoechst 33342 to SCCVII
tumour cells in vitro. Cells were incubated for 2h with
H-33342 at 37°C, and then analysed for clonogenic
potential (a) and for fluorescence intensity (b).
escence. However, from the data shown in Figure 6,
it seems unlikely that differences between cells
change the rate of H-33342 uptake by more than a
factor of 2, at least in the SCCVII tumour. Since
the gradient of drug binding represents a 20-100
fold difference across the tumour, we have not been
concerned with small variations that might occur
between heterogeneous cells exposed to the same
concentration of H-33342. However, this conclusion
is based on the assumption that uptake by single
cells obtained from tumours is the same as uptake by these cells in situ. We are unable to verify whether this is indeed true, just as we cannot
determine absolutely whether the presence of small
amounts of H-33342 in cells interferes with the
toxicity of drugs and radiation (since the sort
cannot be performed without H-33342). Indirect
evidence can be obtained by comparing results with
different doses of H-33342, and assuming that
interactions between H-33342 and drugs should
increase as the concentration of H-33342 increases.
Preisler et al. (1978) have suggested that H-33342
and adriamycin may bind to DNA by similar
mechanisms, and H-33342 treatment might
therefore interact with adriamycin. However, in
their studies, adriamycin was given before H-33342
(20,uM) and appeared to inhibit H-33342 binding
to human leukaemic cells. At the dose of H-33342
(2uM) and time of treatment (20min) used in these
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studies, we observed no change in survival of cells
treated with adriamycin immediately after H-33342
exposure or 2.5h later (when the amount of H-
33342 remaining in the cell had decreased by 50%).
The possibility of using H-33342 to measure
tumour perfusion in a quantitative way is also
being explored. Such studies can be performed by
measuring mean cellular fluorescence using flow
cytometry with tumour cells stained in situ, but
could also be performed by analysing frozen
sections of tumours using microspectrofluorimetry.
In larger tumours, the use of a complementary
stain may be necessary to accurately resolve the
position of tumour cells distant from the blood
supply. Unlike spheroids, where the external cells
directly exposed to H-33342 constitute 10% or
more of the spheroid, the proportion of tumour
cells which are directly exposed to H-33342 is
considerably smaller (i.e., the difference between
inward flow with spherical symmetry and outward
flow with cylindrical symmetry: see Boag, 1969).
This point is illustrated in Figures 3 and 6 where
spheroids and SCCVII tumours were incubated
with H-33342. In Figure 3, spheroids show a 300-
fold difference between the dimmest and brightest
10% of cells, while in Figure 6, there is only a 20-
fold difference. Similarly, the mean cellular
fluorescence is considerably smaller for tumour cells
than for spheroid cells. While transfer could
contribute to the decrease in the H-33342 gradient
in tumours, it seems more likely that differences in
diffusion patterns explain these discrepancies. The
majority of cells in a large tumour with poor
perfusion are exposed to a much smaller
concentration of H-33342 which may not provide
an adequate gradient for effectively sorting cells
distant from the tumour vasculature. To overcome
this problem, other fluorescent stains (excited by
visible light) are being examined which will
preferentially stain cells distant from the blood
supply. Potential stains include fluorescent probes
for hypoxia (Olive & Durand, 1983) or fluorescent
drugs such as fluorescein diacetate which appear to
accumulate in cells at low pH (Chaplin,
unpublished results). When combined with H-
33342, such complementary stains should greatly
enhance the gradient for cell sorting.
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